MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synta Pharmaceuticals Corp. Company Profile (NASDAQ:SNTA)

Consensus Ratings for Synta Pharmaceuticals Corp. (NASDAQ:SNTA) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $3.17 (1,030.95% upside)

Analysts' Ratings History for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Show:
DateFirmActionRatingPrice TargetActions
10/21/2015JMP SecuritiesDowngradeMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Cowen and CompanyDowngradeOutperform -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015FBR & Co.DowngradeOutperform -> Market Perform$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Roth CapitalDowngradeBuy -> Neutral$13.00 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015MLV & Co.Reiterated RatingBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015Canaccord GenuityInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
3/10/2016        
3/15/2016Q4($0.18)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q3($0.16)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.18)($0.15)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.19)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q4($0.21)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q3($0.24)($0.19)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q2($0.27)($0.24)$480.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q1($0.29)($0.28)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2014Q4($0.30)($0.31)$0.37 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2013Q313($0.31)($0.33)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013($0.30)($0.33)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312($0.24)($0.25)$1.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/14/2015Keith R GollustDirectorSell600,000$0.35$210,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Keith R GollustDirectorSell745,892$0.38$283,438.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015Bruce KovnerDirectorSell1,523,346$0.37$563,638.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Bruce KovnerDirectorSell1,430,753$0.43$615,223.79View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/30/2015Bruce KovnerDirectorSell3,078,820$0.48$1,477,833.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2015Bruce KovnerDirectorSell1,173,582$0.44$516,376.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Bruce KovnerDirectorSell1,513,088$0.49$741,413.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Bruce KovnerDirectorSell1,223,936$0.43$526,292.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Bruce KovnerDirectorSell5,436,673$0.55$2,990,170.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Keith R GollustDirectorSell188,322$0.55$103,577.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Robert N WilsonDirectorBuy50,000$1.75$87,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2014Bruce KovnerDirectorBuy300,000$3.08$924,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2014Bruce KovnerDirectorBuy1,250,000$4.01$5,012,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Bruce KovnerDirectorBuy5,000,000$3.75$18,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Safi BahcallCEOBuy20,000$3.75$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/28/2013Safi R BahcallCEOBuy10,000$5.03$50,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2013Bruce KovnerDirectorBuy150,000$4.71$706,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2013Bruce KovnerDirectorBuy500,000$4.53$2,265,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Bruce KovnerDirectorBuy250,000$4.39$1,097,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Safi R BahcallCEOBuy20,000$4.12$82,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Bruce KovnerDirectorBuy200,000$4.00$800,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Safi R BahcallCEOBuy10,000$4.06$40,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2013Bruce KovnerDirectorBuy2,000,000$4.64$9,280,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2013Safi R BahcallCEOBuy10,000$4.04$40,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Vojo VukovicSVPBuy10,000$4.58$45,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2013Robert N WilsonDirectorBuy10,000$5.00$50,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Bruce KovnerDirectorBuy37,700$6.91$260,507.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Safi R BahcallCEOBuy10,000$7.12$71,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
DateHeadline
06/27/16 10:34 AMAnalysts watching two Stocks: Gilead Sciences, Inc. (NASDAQ:GILD) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - Street Updates
06/27/16 10:34 AMHC Stocks Indications: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) - share market updates (press release)
06/24/16 09:04 AMStock on the Move: Synta Pharmaceuticals Corp. (UTC:SNTA) - iStreetWire
06/22/16 11:07 AMSynta Pharmaceuticals To Present At JMP Securities Conference;Webcast At 12:00PM
06/18/16 05:36 PMSynta Pharmaceuticals Corp. (SNTA) Jumps 6.78% on June 17 - Equities.com
06/18/16 10:33 AMSynta Pharmaceuticals Corp. (SNTA) Jumps 6.78% on June 17
06/16/16 06:42 PMBig Movers: Synta Pharmaceuticals Corp. (NASDAQ:SNTA), Civista Bancshares, Inc. (NASDAQ:CIVB), Advanced Micro ... - KC Register
06/16/16 06:42 PMSynta Pharmaceuticals Corp. (SNTA) Drops 7.54% on June 14 - Equities.com
06/16/16 10:54 AMSynta Pharmaceuticals Corp. (SNTA) Drops 7.54% on June 14
06/09/16 06:58 PMGoldberg Law PC (http://www Goldberglawpc com) announces that it is investigating claims of potential misrepresentations by Neovasc, Inc
06/09/16 06:58 PMSynta Announces Date and Location of Annual Meeting of Stockholders to Vote on Merger with Madrigal Pharmaceuticals
06/08/16 07:00 PMSynta Pharmaceuticals Corporation: Synta Announces Date and Location of Annual Meeting of Stockholders to Vote on ... - The Wall Street Transcript
06/03/16 04:16 PMSYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events -
06/02/16 09:41 AMSynta Pharmaceuticals to Present at Upcoming Investor Conferences in June - Business Wire (press release) - Synta Pharmaceuticals to Present at Upcoming Investor Conferences in JuneBusiness Wire (press release)LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (“Synta”) (NASDAQ:SNTA) today announced that Marc Schneebaum, Chief Financial Officer of Synta, will be joined by Paul Friedman, M.D., designated Chairman and Chief Executive ...and more »
06/02/16 06:15 AMSynta Pharmaceuticals to Present at Upcoming Investor Conferences in June - [at noodls] - LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 2, 2016-- Synta Pharmaceuticals Corp. ('Synta') (NASDAQ:SNTA) today announced that Marc Schneebaum, Chief Financial Officer of Synta, will be joined by Paul Friedman, ...
05/31/16 06:53 PMSynta Pharmaceuticals Corp. (NASDAQ:SNTA) increased 0.25%: Galapagos NV (NASDAQ:GLPG), CNA Financial ... - KC Register - Synta Pharmaceuticals Corp. (NASDAQ:SNTA) increased 0.25%: Galapagos NV (NASDAQ:GLPG), CNA Financial ...KC RegisterOn Friday Synta Pharmaceuticals Corp. (NASDAQ:SNTA) share price closed at $0.36. Company return on equity (ROE) is -97.30%. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is -5.71% away from its 52 week high and its 52 week range is $0.1500 ...
05/30/16 10:18 PMSynta Pharmaceuticals Corp. (SNTA) Broker Price Targets For The Coming Week - Share Trading News - Synta Pharmaceuticals Corp. (SNTA) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Synta Pharmaceuticals Corp. (SNTA). The latest reports which are currently in issue on Monday 30th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...Synta Pharmaceuticals Incorporated (NASDAQ:SNTA) Sellers Increased By 9.63% Their ShortsHNNall 2 news articles »
05/27/16 10:55 PMSynta Pharmaceuticals : Why Biotech Stocks Fascinate Investors? - Synta Pharma, CTI BioPharma, Lpath, and Heat Biologics - Additionally, shares of Synta Pharmaceuticals have a Relative Strength Index (RSI) of 48.50. Sign up and get the alert on SNTA at: http://www.activewallst.com/register On Thursday, shares in biopharma Company, CTI BioPharma Corp., ended the session at $0 ...
05/27/16 10:55 PMSynta Pharmaceuticals Corp. (SNTA) Drops 5.11% on May 26 - Synta Pharmaceuticals Corp. (SNTA) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 5.11% to $0.36, a loss of $-0.0194 per share. Starting at an opening price of $0.37 a share, the stock traded between $0.36 and $0.39 over ...
05/27/16 05:47 PMSynta Pharmaceuticals Corp. (SNTA) Drops 5.11% on May 26 - Equities.com - Synta Pharmaceuticals Corp. (SNTA) Drops 5.11% on May 26Equities.comSynta Pharmaceuticals Corp. (SNTA) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 5.11% to $0.36, a loss of $-0.0194 per share. Starting at an opening price of $0.37 a share, the stock traded between $0.36 and $0.39 ...Synta Pharmaceuticals Corp. (SNTA) Analyst ReviewRisers & Fallersall 3 news articles »
05/26/16 05:37 PMSynta Pharmaceuticals Incorporated (NASDAQ:SNTA) Sellers Covered 5.44% of Their Shorts - Wall Street Hints and News - Synta Pharmaceuticals Incorporated (NASDAQ:SNTA) Sellers Covered 5.44% of Their ShortsWall Street Hints and NewsThe short interest to Synta Pharmaceuticals Incorporated's float is 5.71%. The stock increased 2.70% or $0.01 during the last trading session, hitting $0.38. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) has declined 81.37% since October 20, 2015 and is ...
05/22/16 10:06 PMAfter Last Week What Do Analysts Think Of Synta Pharmaceuticals Corp. (SNTA) - Share Trading News - After Last Week What Do Analysts Think Of Synta Pharmaceuticals Corp. (SNTA)Share Trading News10/21/2015 – Synta Pharmaceuticals Corp. had its “mkt perform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 2 price target on the stock. 10/21/2015 – Synta Pharmaceuticals Corp. was downgraded to “neutral” by analysts at ...Alpha One Assigns Impact Score Of 84 To Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Investor NewswireAfter Recent Decline, is it Time to Sell Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Franklin Independentall 3 news articles »
05/22/16 10:06 AMAlpha One Assigns Impact Score Of 84 To Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - Investor Newswire - Alpha One Assigns Impact Score Of 84 To Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Investor NewswireAlpha One analyzed the various web articles published on Synta Pharmaceuticals Corp. (NASDAQ:SNTA), and thereafter it gave company a daily sentiment score of -0.29. The entity designs algorithm based assessment to known stock sentiment on stock ...After Recent Decline, is it Time to Sell Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Franklin Independentall 2 news articles »
05/20/16 10:37 PMRevenue Update on Synta Pharmaceuticals Corp.(NASDAQ:SNTA) - Trade Calls - Revenue Update on Synta Pharmaceuticals Corp.(NASDAQ:SNTA)Trade CallsSynta Pharmaceuticals Corp.(NASDAQ:SNTA) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 10, 2016. Earnings per share were $-0.05. Analysts had estimated an EPS of $-0.03.Synta Pharmaceuticals Corp. (SNTA) Drops 5.6% on May 18Equities.comLatest Analyst Ratings For Synta Pharmaceuticals Corp. (SNTA)Share Trading NewsHow Many Synta Pharmaceuticals Corp. (NASDAQ:SNTA)'s Analysts Are Bullish?Wall Street Hints and NewsRisers & Fallersall 6 news articles »
05/20/16 05:29 PMSynta Pharmaceuticals Corp. (SNTA) Drops 5.6% on May 18 - Synta Pharmaceuticals Corp. (SNTA) was one of the Russell 2000's biggest losers for Wednesday May 18 as the stock slid 5.6% to $0.36, a loss of $-0.0214 per share. Starting at an opening price of $0.38 a share, the stock traded between $0.36 and $0.39 over ...
05/19/16 10:42 PMSynta Pharmaceuticals Corp. (SNTA) Drops 5.6% on May 18 - Equities.com - Synta Pharmaceuticals Corp. (SNTA) Drops 5.6% on May 18Equities.comSynta Pharmaceuticals Corp. (SNTA) was one of the Russell 2000's biggest losers for Wednesday May 18 as the stock slid 5.6% to $0.36, a loss of $-0.0214 per share. Starting at an opening price of $0.38 a share, the stock traded between $0.36 and $0.39 ...Recently Changed Price Targets On Synta Pharmaceuticals Corp. (SNTA)Risers & FallersSynta Pharmaceuticals Incorporated (NASDAQ:SNTA) Shorted Shares Decreased By 5.44%The Postall 3 news articles »
05/19/16 12:04 PMSYNTA PHARMACEUTICALS CORP Financials -
05/16/16 03:00 PMVKTX: Phase 2 Study of VK5211 for Hip Fracture Ongoing; Phase 2 Study of VK2809 for Hypercholersterolemia to Commence in mid-2016 -
05/16/16 10:31 AMSynta Pharmaceuticals Corp. (NASDAQ:SNTA) Latest Impact Score At 84 - Investor Newswire - Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Latest Impact Score At 84Investor NewswireSynta Pharmaceuticals Corp. (NASDAQ:SNTA) has a -0.29 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published ...Synta Pharmaceuticals Corp. (SNTA) Jumps 5.01% on May 12Equities.comCurrent Price Targets For Synta Pharmaceuticals Corp. (SNTA)Risers & FallersMost recent Analysts Rating report: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) , Synta Pharmaceuticals Corp ...Street Updatesall 7 news articles »
05/14/16 05:12 PMSynta Pharmaceuticals Corp. (SNTA) Jumps 5.01% on May 12 - Synta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Thursday May 12 as the stock popped 5.01% to $0.44, representing a gain of $0.021 per share. Some 1.09 million shares traded hands on 1,802 trades, compared with an ...
05/14/16 04:04 AMSynta Pharmaceuticals Corp. (SNTA) Jumps 5.01% on May 12 - Equities.com - Synta Pharmaceuticals Corp. (SNTA) Jumps 5.01% on May 12Equities.comSynta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Thursday May 12 as the stock popped 5.01% to $0.44, representing a gain of $0.021 per share. Some 1.09 million shares traded hands on 1,802 trades, compared ...Current Price Targets For Synta Pharmaceuticals Corp. (SNTA)Risers & Fallersall 10 news articles »
05/13/16 04:10 AMSynta Pharmaceuticals Corp. (SNTA) Jumps 7.55% on May 11 - Synta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Wednesday May 11 as the stock popped 7.55% to $0.42, representing a gain of $0.0294 per share. Some 941,112 shares traded hands on 1,565 trades, compared with an ...
05/12/16 11:01 PMSynta Pharmaceuticals Corp. (SNTA) Jumps 7.55% on May 11 - Equities.com - Synta Pharmaceuticals Corp. (SNTA) Jumps 7.55% on May 11Equities.comSynta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Wednesday May 11 as the stock popped 7.55% to $0.42, representing a gain of $0.0294 per share. Some 941,112 shares traded hands on 1,565 trades, compared ...How Many Synta Pharmaceuticals Corp. (NASDAQ:SNTA)'s Analysts Are Bullish?Franklin Independentall 2 news articles »
05/12/16 05:53 PMStock Earnings Review: Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - News Oracle - Stock Earnings Review: Synta Pharmaceuticals Corp. (NASDAQ:SNTA)News OracleLast Trade: The Company rose 7.55% and finished at $0.419. The daily volume was measured at 948,652.00 shares. The 52-week high of the share price is $2.65 and the 52-week low is $0.15. The company has a market cap of $59.20 million. Its latest ...
05/11/16 09:13 AMSynta (SNTA) Lowers Q1 Loss Y/Y, Focus on Madrigal Merger -
05/10/16 08:27 AMSynta reports 1Q loss -
05/10/16 07:34 AMSYNTA PHARMACEUTICALS CORP Files SEC form 10-Q, Quarterly Report -
05/09/16 05:42 PMReview of Price Trends: Cara Therapeutics, Inc. (NASDAQ:CARA) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - Street Updates - Review of Price Trends: Cara Therapeutics, Inc. (NASDAQ:CARA) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Street UpdatesIn the past trading session, Synta Pharmaceuticals Corp. (NASDAQ:SNTA) highlighted upward shift of +1.6523% or +0.0065 points to $0.3999. The company traded a volume of 461.64 thousand shares under average volume of 1.33 million shares. Trailing ...
05/06/16 04:25 AMBroker Roundup For Synta Pharmaceuticals Corp. (SNTA) - Share Trading News - Zacks.comBroker Roundup For Synta Pharmaceuticals Corp. (SNTA)Share Trading News11/05/2013 – Synta Pharmaceuticals Corp. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 19 price target on the stock. The share price of Synta Pharmaceuticals Corp. (SNTA) was down -0.69% during the last trading session, ...Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Basic Consolidated EPS At $-0.534RealistInvestor.comThe Key Numbers To Watch From Synta Pharmaceuticals Corp. (SNTA)'s EarningsStreet RegisterWhat's in the Cards for Synta (SNTA) This Earnings Season?Zacks.comall 5 news articles »
05/05/16 04:03 AMWhat's in the Cards for Synta (SNTA) This Earnings Season? - Synta Pharmaceuticals Corp. (SNTA - Analyst Report) is expected to report first-quarter 2016 results on May 5. This Zacks Rank #3 (Hold) stock has a pretty good track record with the company beating expectations on two occasions, while posting in line ...
05/04/16 05:47 PMThis Weeks Broker Price Targets For Synta Pharmaceuticals Corp. (SNTA) - Share Trading News - This Weeks Broker Price Targets For Synta Pharmaceuticals Corp. (SNTA)Share Trading NewsSynta Pharmaceuticals Corp. has a 50 day moving average of 0.29 and a 200 day moving average of 0.41. The stock's market capitalization is 54.93M, it has a 52-week low of 0.15 and a 52-week high of 2.65. The share price of the company (SNTA) was ...
05/03/16 07:16 AMSYNTA PHARMACEUTICALS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
05/01/16 06:23 PMSynta Pharmaceuticals Corp. (NASDAQ:SNTA) Boasts An Average Rating Of 3.5 - Investor Newswire - Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Boasts An Average Rating Of 3.5Investor NewswireAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. Synta Pharmaceuticals Corp.and more »
04/29/16 05:54 PMHow Many Synta Pharmaceuticals Corp. (NASDAQ:SNTA)'s Analysts Are Bullish? - B.O.D.Y Confidential - How Many Synta Pharmaceuticals Corp. (NASDAQ:SNTA)'s Analysts Are Bullish?B.O.D.Y ConfidentialOut of 1 analysts covering Synta Pharmaceuticals Corp. (NASDAQ:SNTA), 0 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 0% are positive. Synta Pharmaceuticals Corp. has been the topic of 4 analyst reports since August 10, 2015 according to ...
04/29/16 05:54 PMRecent Update on Price Movements: Alkermes plc (NASDAQ:ALKS) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA) - Street Updates - Recent Update on Price Movements: Alkermes plc (NASDAQ:ALKS) , Synta Pharmaceuticals Corp. (NASDAQ:SNTA)Street UpdatesSynta Pharmaceuticals Corp. (NASDAQ:SNTA) moved in green zone with rise of +0.028 points or +7.261% to $0.421. The company has a market worth of $57.82M.Total 1.29 million shares were exchanged in last trading session as opposed to average ...and more »
04/28/16 06:09 PMSynta Pharmaceuticals Corp. (SNTA) Updated Broker Price Targets - Share Trading News - Synta Pharmaceuticals Corp. (SNTA) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Synta Pharmaceuticals Corp. (SNTA). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...
04/28/16 06:09 PMSynta Pharmaceuticals Corp. (SNTA) Jumps 7.26% on April 28 - Equities.com - Synta Pharmaceuticals Corp. (SNTA) Jumps 7.26% on April 28Equities.comSynta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Thursday April 28 as the stock popped 7.26% to $0.42, representing a gain of $0.0285 per share. Some 1.29 million shares traded hands on 2,086 trades, compared ...Synta Pharmaceuticals Incorporated (NASDAQ:SNTA) Shorted Shares Increased By 7.1%Franklin Independentall 2 news articles »
04/21/16 08:30 AMThe Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen -
04/20/16 03:38 PMBiotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal -
04/15/16 10:30 AMSynta Stock Up on Merger Deal with Madrigal Pharmaceuticals -
About Synta Pharmaceuticals Corp.

Synta Pharmaceuticals Corp. logoSynta Pharmaceuticals Corp. is focused on research, development and commercialization of oncology medicines. The Company's segment is the discovery, development and commercialization of drug products. It has a clinical-stage drug candidate in oncology (ganetespib), and a small molecule cancer drug development program (heat shock protein 90 (Hsp90) inhibitor Drug Conjugate (HDC) program). It is engaged in evaluating various candidates from its HDC program, which leverages the preferential accumulation of Hsp90 inhibitors in tumors to selectively deliver a range of anti-cancer payloads. Ganetespib is a small molecule inhibitor of Hsp90, a molecular chaperone that is required for the folding and activation of various cancer-promoting proteins. It is engaged in conducting preclinical studies for its clinical candidate from the HDC program, STA-12-8666. It holds interests in its drug candidate, elesclomol, and the calcium release-activated calcium modulator (CRACM) inhibitor program.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SNTA
  • CUSIP: 87162T20
Key Metrics:
  • Previous Close: $0.26
  • 50 Day Moving Average: $0.36
  • 200 Day Moving Average: $0.30
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $38.47M
  • Current Quarter EPS Consensus Estimate: $-0.07 EPS
Additional Links:
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha